IDH1 and central nervous system cancer: This phenomenon is sustained by an enhanced amount of DNA damage in IDH1-mutated malignant glioma cells and thereby IDH1/2 mutations operate as driver mutations in glioma carcinogenesis, although their primary role is still unexplored [9].